nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinolone Acetonide—NR3C1—epilepsy syndrome	0.574	1	CbGaD
Fluocinolone Acetonide—SERPINA6—hindbrain—epilepsy syndrome	0.00329	0.151	CbGeAlD
Fluocinolone Acetonide—NR3C1—hindbrain—epilepsy syndrome	0.00144	0.066	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—medulla oblongata—epilepsy syndrome	0.00132	0.0605	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—midbrain—epilepsy syndrome	0.00121	0.0553	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—spinal cord—epilepsy syndrome	0.00118	0.0539	CbGeAlD
Fluocinolone Acetonide—SERPINA6—head—epilepsy syndrome	0.00104	0.0477	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—nervous system—epilepsy syndrome	0.000992	0.0455	CbGeAlD
Fluocinolone Acetonide—SERPINA6—nervous system—epilepsy syndrome	0.000988	0.0453	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—central nervous system—epilepsy syndrome	0.000955	0.0438	CbGeAlD
Fluocinolone Acetonide—SERPINA6—central nervous system—epilepsy syndrome	0.000951	0.0436	CbGeAlD
Fluocinolone Acetonide—SERPINA6—cerebellum—epilepsy syndrome	0.00093	0.0426	CbGeAlD
Fluocinolone Acetonide—NR3C1—brainstem—epilepsy syndrome	0.000826	0.0378	CbGeAlD
Fluocinolone Acetonide—NR3C1—forebrain—epilepsy syndrome	0.000797	0.0365	CbGeAlD
Fluocinolone Acetonide—PLA2G4A—brain—epilepsy syndrome	0.000758	0.0347	CbGeAlD
Fluocinolone Acetonide—SERPINA6—brain—epilepsy syndrome	0.000755	0.0346	CbGeAlD
Fluocinolone Acetonide—NR3C1—telencephalon—epilepsy syndrome	0.000733	0.0336	CbGeAlD
Fluocinolone Acetonide—NR3C1—medulla oblongata—epilepsy syndrome	0.000576	0.0264	CbGeAlD
Fluocinolone Acetonide—NR3C1—midbrain—epilepsy syndrome	0.000526	0.0241	CbGeAlD
Fluocinolone Acetonide—NR3C1—spinal cord—epilepsy syndrome	0.000514	0.0235	CbGeAlD
Fluocinolone Acetonide—NR3C1—head—epilepsy syndrome	0.000456	0.0209	CbGeAlD
Fluocinolone Acetonide—NR3C1—nervous system—epilepsy syndrome	0.000433	0.0198	CbGeAlD
Fluocinolone Acetonide—NR3C1—central nervous system—epilepsy syndrome	0.000417	0.0191	CbGeAlD
Fluocinolone Acetonide—NR3C1—cerebellum—epilepsy syndrome	0.000407	0.0187	CbGeAlD
Fluocinolone Acetonide—Prednisolone—SLCO1A2—epilepsy syndrome	0.000382	0.0454	CrCbGaD
Fluocinolone Acetonide—Difluprednate—NR3C1—epilepsy syndrome	0.000358	0.0427	CrCbGaD
Fluocinolone Acetonide—Clocortolone—NR3C1—epilepsy syndrome	0.000348	0.0414	CrCbGaD
Fluocinolone Acetonide—NR3C1—brain—epilepsy syndrome	0.000331	0.0152	CbGeAlD
Fluocinolone Acetonide—Diflorasone—NR3C1—epilepsy syndrome	0.000329	0.0391	CrCbGaD
Fluocinolone Acetonide—Desonide—NR3C1—epilepsy syndrome	0.000329	0.0391	CrCbGaD
Fluocinolone Acetonide—Desoximetasone—NR3C1—epilepsy syndrome	0.000321	0.0382	CrCbGaD
Fluocinolone Acetonide—Flurandrenolide—NR3C1—epilepsy syndrome	0.000281	0.0334	CrCbGaD
Fluocinolone Acetonide—Flumethasone Pivalate—NR3C1—epilepsy syndrome	0.000276	0.0329	CrCbGaD
Fluocinolone Acetonide—Halobetasol Propionate—NR3C1—epilepsy syndrome	0.000272	0.0323	CrCbGaD
Fluocinolone Acetonide—Budesonide—NR3C1—epilepsy syndrome	0.000253	0.0301	CrCbGaD
Fluocinolone Acetonide—Amcinonide—NR3C1—epilepsy syndrome	0.000253	0.0301	CrCbGaD
Fluocinolone Acetonide—Fluticasone furoate—NR3C1—epilepsy syndrome	0.000248	0.0295	CrCbGaD
Fluocinolone Acetonide—Mometasone—NR3C1—epilepsy syndrome	0.00024	0.0286	CrCbGaD
Fluocinolone Acetonide—Rimexolone—NR3C1—epilepsy syndrome	0.000237	0.0283	CrCbGaD
Fluocinolone Acetonide—Beclomethasone—NR3C1—epilepsy syndrome	0.000224	0.0267	CrCbGaD
Fluocinolone Acetonide—Fluocinonide—NR3C1—epilepsy syndrome	0.000224	0.0267	CrCbGaD
Fluocinolone Acetonide—Alclometasone—NR3C1—epilepsy syndrome	0.000218	0.0259	CrCbGaD
Fluocinolone Acetonide—Dexamethasone—SLCO1A2—epilepsy syndrome	0.000218	0.0259	CrCbGaD
Fluocinolone Acetonide—Clobetasol propionate—NR3C1—epilepsy syndrome	0.000212	0.0252	CrCbGaD
Fluocinolone Acetonide—Flunisolide—NR3C1—epilepsy syndrome	0.000212	0.0252	CrCbGaD
Fluocinolone Acetonide—Fludrocortisone—NR3C1—epilepsy syndrome	0.000212	0.0252	CrCbGaD
Fluocinolone Acetonide—Paramethasone—NR3C1—epilepsy syndrome	0.000209	0.0249	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—BCHE—epilepsy syndrome	0.000205	0.0244	CrCbGaD
Fluocinolone Acetonide—Fluorometholone—NR3C1—epilepsy syndrome	0.000204	0.0243	CrCbGaD
Fluocinolone Acetonide—Nausea—Clobazam—epilepsy syndrome	0.000198	0.000604	CcSEcCtD
Fluocinolone Acetonide—Methylprednisolone—NR3C1—epilepsy syndrome	0.000197	0.0235	CrCbGaD
Fluocinolone Acetonide—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000197	0.000601	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Acetazolamide—epilepsy syndrome	0.000196	0.000599	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000196	0.000599	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Propofol—epilepsy syndrome	0.000195	0.000595	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Pregabalin—epilepsy syndrome	0.000195	0.000595	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000194	0.000594	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000194	0.000593	CcSEcCtD
Fluocinolone Acetonide—Back pain—Valproic Acid—epilepsy syndrome	0.000194	0.000593	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000193	0.00059	CcSEcCtD
Fluocinolone Acetonide—Pain—Clonazepam—epilepsy syndrome	0.000192	0.000588	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000192	0.000586	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Gabapentin—epilepsy syndrome	0.000192	0.000586	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Midazolam—epilepsy syndrome	0.000191	0.000582	CcSEcCtD
Fluocinolone Acetonide—Pain—Oxcarbazepine—epilepsy syndrome	0.00019	0.000581	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—CYP11A1—epilepsy syndrome	0.000189	0.0225	CrCbGaD
Fluocinolone Acetonide—Vision blurred—Valproic Acid—epilepsy syndrome	0.000189	0.000578	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Felbamate—epilepsy syndrome	0.000189	0.000576	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Acetazolamide—epilepsy syndrome	0.000189	0.000576	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Propofol—epilepsy syndrome	0.000188	0.000576	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Levetiracetam—epilepsy syndrome	0.000188	0.000575	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000188	0.000574	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000188	0.000574	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000188	0.000574	CcSEcCtD
Fluocinolone Acetonide—Upper respiratory tract infection—Topiramate—epilepsy syndrome	0.000187	0.000571	CcSEcCtD
Fluocinolone Acetonide—Headache—Acetazolamide—epilepsy syndrome	0.000186	0.000567	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Zonisamide—epilepsy syndrome	0.000185	0.000564	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000184	0.000563	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Gabapentin—epilepsy syndrome	0.000184	0.000563	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Pregabalin—epilepsy syndrome	0.000184	0.000563	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000184	0.000563	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Pregabalin—epilepsy syndrome	0.000183	0.000558	CcSEcCtD
Fluocinolone Acetonide—Pain—Carbamazepine—epilepsy syndrome	0.000182	0.000557	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Propofol—epilepsy syndrome	0.000182	0.000556	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000182	0.000556	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Fosphenytoin—epilepsy syndrome	0.000182	0.000555	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Diazepam—epilepsy syndrome	0.000182	0.000555	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Pregabalin—epilepsy syndrome	0.000181	0.000554	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Valproic Acid—epilepsy syndrome	0.00018	0.000551	CcSEcCtD
Fluocinolone Acetonide—Infestation—Topiramate—epilepsy syndrome	0.000179	0.000547	CcSEcCtD
Fluocinolone Acetonide—Infestation NOS—Topiramate—epilepsy syndrome	0.000179	0.000547	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Gabapentin—epilepsy syndrome	0.000179	0.000546	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Midazolam—epilepsy syndrome	0.000178	0.000544	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.000178	0.000544	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Clonazepam—epilepsy syndrome	0.000178	0.000543	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Pregabalin—epilepsy syndrome	0.000178	0.000543	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Vigabatrin—epilepsy syndrome	0.000177	0.000541	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Phenytoin—epilepsy syndrome	0.000177	0.00054	CcSEcCtD
Fluocinolone Acetonide—Pain—Lamotrigine—epilepsy syndrome	0.000176	0.000539	CcSEcCtD
Fluocinolone Acetonide—Nausea—Acetazolamide—epilepsy syndrome	0.000176	0.000538	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Levetiracetam—epilepsy syndrome	0.000176	0.000538	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000176	0.000537	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000176	0.000537	CcSEcCtD
Fluocinolone Acetonide—Back pain—Pregabalin—epilepsy syndrome	0.000176	0.000536	CcSEcCtD
Fluocinolone Acetonide—Cough—Valproic Acid—epilepsy syndrome	0.000175	0.000535	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Propofol—epilepsy syndrome	0.000175	0.000535	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Diazepam—epilepsy syndrome	0.000174	0.000533	CcSEcCtD
Fluocinolone Acetonide—Rash—Propofol—epilepsy syndrome	0.000174	0.00053	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Propofol—epilepsy syndrome	0.000173	0.00053	CcSEcCtD
Fluocinolone Acetonide—Headache—Propofol—epilepsy syndrome	0.000173	0.000527	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000172	0.000526	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000172	0.000526	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Midazolam—epilepsy syndrome	0.000171	0.000523	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000171	0.000523	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Pregabalin—epilepsy syndrome	0.000171	0.000523	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Valproic Acid—epilepsy syndrome	0.000171	0.000522	CcSEcCtD
Fluocinolone Acetonide—Rash—Midazolam—epilepsy syndrome	0.00017	0.000519	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Fosphenytoin—epilepsy syndrome	0.00017	0.000519	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Midazolam—epilepsy syndrome	0.00017	0.000519	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Levetiracetam—epilepsy syndrome	0.000169	0.000517	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Gabapentin—epilepsy syndrome	0.000169	0.000516	CcSEcCtD
Fluocinolone Acetonide—Headache—Midazolam—epilepsy syndrome	0.000169	0.000516	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Felbamate—epilepsy syndrome	0.000169	0.000516	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000169	0.000515	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Diazepam—epilepsy syndrome	0.000169	0.000515	CcSEcCtD
Fluocinolone Acetonide—Sinusitis—Topiramate—epilepsy syndrome	0.000168	0.000514	CcSEcCtD
Fluocinolone Acetonide—Rash—Levetiracetam—epilepsy syndrome	0.000168	0.000513	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Levetiracetam—epilepsy syndrome	0.000168	0.000512	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Gabapentin—epilepsy syndrome	0.000167	0.000512	CcSEcCtD
Fluocinolone Acetonide—Headache—Levetiracetam—epilepsy syndrome	0.000167	0.000509	CcSEcCtD
Fluocinolone Acetonide—Triamcinolone—NR3C1—epilepsy syndrome	0.000167	0.0198	CrCbGaD
Fluocinolone Acetonide—Erythema—Gabapentin—epilepsy syndrome	0.000166	0.000508	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Gabapentin—epilepsy syndrome	0.000166	0.000508	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000166	0.000506	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Vigabatrin—epilepsy syndrome	0.000166	0.000506	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Zonisamide—epilepsy syndrome	0.000165	0.000505	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000165	0.000503	CcSEcCtD
Fluocinolone Acetonide—Oedema—Valproic Acid—epilepsy syndrome	0.000164	0.000501	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000164	0.0005	CcSEcCtD
Fluocinolone Acetonide—Nausea—Propofol—epilepsy syndrome	0.000164	0.0005	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Fosphenytoin—epilepsy syndrome	0.000163	0.000499	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Felbamate—epilepsy syndrome	0.000163	0.000499	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Pregabalin—epilepsy syndrome	0.000163	0.000498	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000163	0.000498	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Gabapentin—epilepsy syndrome	0.000163	0.000498	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Diazepam—epilepsy syndrome	0.000163	0.000498	CcSEcCtD
Fluocinolone Acetonide—Infection—Valproic Acid—epilepsy syndrome	0.000163	0.000497	CcSEcCtD
Fluocinolone Acetonide—Rash—Fosphenytoin—epilepsy syndrome	0.000162	0.000495	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000162	0.000494	CcSEcCtD
Fluocinolone Acetonide—Rhinitis—Topiramate—epilepsy syndrome	0.000161	0.000493	CcSEcCtD
Fluocinolone Acetonide—Back pain—Gabapentin—epilepsy syndrome	0.000161	0.000492	CcSEcCtD
Fluocinolone Acetonide—Headache—Fosphenytoin—epilepsy syndrome	0.000161	0.000491	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000161	0.000491	CcSEcCtD
Fluocinolone Acetonide—Nausea—Midazolam—epilepsy syndrome	0.00016	0.000489	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Zonisamide—epilepsy syndrome	0.00016	0.000488	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Clonazepam—epilepsy syndrome	0.000159	0.000486	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Vigabatrin—epilepsy syndrome	0.000159	0.000486	CcSEcCtD
Fluocinolone Acetonide—Cough—Pregabalin—epilepsy syndrome	0.000158	0.000484	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Phenytoin—epilepsy syndrome	0.000158	0.000483	CcSEcCtD
Fluocinolone Acetonide—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000158	0.000483	CcSEcCtD
Fluocinolone Acetonide—Nausea—Levetiracetam—epilepsy syndrome	0.000158	0.000483	CcSEcCtD
Fluocinolone Acetonide—Rash—Vigabatrin—epilepsy syndrome	0.000158	0.000482	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Felbamate—epilepsy syndrome	0.000158	0.000482	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Vigabatrin—epilepsy syndrome	0.000158	0.000482	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000157	0.000481	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000157	0.00048	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—NOS2—epilepsy syndrome	0.000157	0.0187	CrCbGaD
Fluocinolone Acetonide—Vision blurred—Gabapentin—epilepsy syndrome	0.000157	0.000479	CcSEcCtD
Fluocinolone Acetonide—Headache—Vigabatrin—epilepsy syndrome	0.000157	0.000479	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Diazepam—epilepsy syndrome	0.000157	0.000479	CcSEcCtD
Fluocinolone Acetonide—Rash—Diazepam—epilepsy syndrome	0.000155	0.000475	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Diazepam—epilepsy syndrome	0.000155	0.000474	CcSEcCtD
Fluocinolone Acetonide—Visual impairment—Topiramate—epilepsy syndrome	0.000155	0.000474	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Pregabalin—epilepsy syndrome	0.000155	0.000472	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Zonisamide—epilepsy syndrome	0.000154	0.000472	CcSEcCtD
Fluocinolone Acetonide—Headache—Diazepam—epilepsy syndrome	0.000154	0.000472	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Clonazepam—epilepsy syndrome	0.000154	0.00047	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Phenytoin—epilepsy syndrome	0.000153	0.000467	CcSEcCtD
Fluocinolone Acetonide—Nausea—Fosphenytoin—epilepsy syndrome	0.000153	0.000466	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000152	0.000465	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000152	0.000464	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Felbamate—epilepsy syndrome	0.000152	0.000463	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Carbamazepine—epilepsy syndrome	0.000151	0.000461	CcSEcCtD
Fluocinolone Acetonide—Rash—Felbamate—epilepsy syndrome	0.00015	0.000459	CcSEcCtD
Fluocinolone Acetonide—Eye disorder—Topiramate—epilepsy syndrome	0.00015	0.000459	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Felbamate—epilepsy syndrome	0.00015	0.000459	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Gabapentin—epilepsy syndrome	0.00015	0.000457	CcSEcCtD
Fluocinolone Acetonide—Headache—Felbamate—epilepsy syndrome	0.000149	0.000456	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000149	0.000456	CcSEcCtD
Fluocinolone Acetonide—Fluticasone Propionate—NR3C1—epilepsy syndrome	0.000149	0.0177	CrCbGaD
Fluocinolone Acetonide—Dizziness—Clonazepam—epilepsy syndrome	0.000149	0.000455	CcSEcCtD
Fluocinolone Acetonide—Nausea—Vigabatrin—epilepsy syndrome	0.000149	0.000454	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Zonisamide—epilepsy syndrome	0.000148	0.000454	CcSEcCtD
Fluocinolone Acetonide—Oedema—Pregabalin—epilepsy syndrome	0.000148	0.000453	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Phenytoin—epilepsy syndrome	0.000148	0.000452	CcSEcCtD
Fluocinolone Acetonide—Rash—Zonisamide—epilepsy syndrome	0.000147	0.00045	CcSEcCtD
Fluocinolone Acetonide—Infection—Pregabalin—epilepsy syndrome	0.000147	0.00045	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Zonisamide—epilepsy syndrome	0.000147	0.000449	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000147	0.000449	CcSEcCtD
Fluocinolone Acetonide—Nausea—Diazepam—epilepsy syndrome	0.000146	0.000447	CcSEcCtD
Fluocinolone Acetonide—Headache—Zonisamide—epilepsy syndrome	0.000146	0.000447	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000146	0.000446	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Lamotrigine—epilepsy syndrome	0.000146	0.000446	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000145	0.000444	CcSEcCtD
Fluocinolone Acetonide—Cough—Gabapentin—epilepsy syndrome	0.000145	0.000444	CcSEcCtD
Fluocinolone Acetonide—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000145	0.000443	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Clonazepam—epilepsy syndrome	0.000143	0.000437	CcSEcCtD
Fluocinolone Acetonide—Alopecia—Topiramate—epilepsy syndrome	0.000142	0.000434	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Phenytoin—epilepsy syndrome	0.000142	0.000434	CcSEcCtD
Fluocinolone Acetonide—Rash—Clonazepam—epilepsy syndrome	0.000142	0.000433	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Clonazepam—epilepsy syndrome	0.000142	0.000433	CcSEcCtD
Fluocinolone Acetonide—Arthralgia—Gabapentin—epilepsy syndrome	0.000142	0.000433	CcSEcCtD
Fluocinolone Acetonide—Nausea—Felbamate—epilepsy syndrome	0.000142	0.000433	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000141	0.000432	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000141	0.000432	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Carbamazepine—epilepsy syndrome	0.000141	0.000431	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000141	0.000431	CcSEcCtD
Fluocinolone Acetonide—Headache—Clonazepam—epilepsy syndrome	0.000141	0.000431	CcSEcCtD
Fluocinolone Acetonide—Rash—Phenytoin—epilepsy syndrome	0.000141	0.000431	CcSEcCtD
Fluocinolone Acetonide—Mental disorder—Topiramate—epilepsy syndrome	0.000141	0.000431	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Phenytoin—epilepsy syndrome	0.000141	0.00043	CcSEcCtD
Fluocinolone Acetonide—Rash—Oxcarbazepine—epilepsy syndrome	0.00014	0.000428	CcSEcCtD
Fluocinolone Acetonide—Pain—Valproic Acid—epilepsy syndrome	0.00014	0.000428	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.00014	0.000428	CcSEcCtD
Fluocinolone Acetonide—Headache—Phenytoin—epilepsy syndrome	0.00014	0.000428	CcSEcCtD
Fluocinolone Acetonide—Erythema—Topiramate—epilepsy syndrome	0.00014	0.000428	CcSEcCtD
Fluocinolone Acetonide—Malnutrition—Topiramate—epilepsy syndrome	0.00014	0.000428	CcSEcCtD
Fluocinolone Acetonide—Headache—Oxcarbazepine—epilepsy syndrome	0.000139	0.000426	CcSEcCtD
Fluocinolone Acetonide—Prednisolone—NR3C1—epilepsy syndrome	0.000139	0.0166	CrCbGaD
Fluocinolone Acetonide—Nausea—Zonisamide—epilepsy syndrome	0.000139	0.000424	CcSEcCtD
Fluocinolone Acetonide—Dysgeusia—Topiramate—epilepsy syndrome	0.000137	0.000419	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—NR3C1—epilepsy syndrome	0.000136	0.0162	CrCbGaD
Fluocinolone Acetonide—Dizziness—Lamotrigine—epilepsy syndrome	0.000136	0.000417	CcSEcCtD
Fluocinolone Acetonide—Oedema—Gabapentin—epilepsy syndrome	0.000136	0.000415	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Carbamazepine—epilepsy syndrome	0.000136	0.000414	CcSEcCtD
Fluocinolone Acetonide—Back pain—Topiramate—epilepsy syndrome	0.000135	0.000414	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000135	0.000412	CcSEcCtD
Fluocinolone Acetonide—Infection—Gabapentin—epilepsy syndrome	0.000135	0.000412	CcSEcCtD
Fluocinolone Acetonide—Rash—Carbamazepine—epilepsy syndrome	0.000135	0.000411	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Carbamazepine—epilepsy syndrome	0.000134	0.000411	CcSEcCtD
Fluocinolone Acetonide—Nausea—Clonazepam—epilepsy syndrome	0.000134	0.000408	CcSEcCtD
Fluocinolone Acetonide—Headache—Carbamazepine—epilepsy syndrome	0.000134	0.000408	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000133	0.000407	CcSEcCtD
Fluocinolone Acetonide—Nausea—Phenytoin—epilepsy syndrome	0.000133	0.000406	CcSEcCtD
Fluocinolone Acetonide—Nausea—Oxcarbazepine—epilepsy syndrome	0.000132	0.000403	CcSEcCtD
Fluocinolone Acetonide—Vision blurred—Topiramate—epilepsy syndrome	0.000132	0.000403	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Lamotrigine—epilepsy syndrome	0.000131	0.000401	CcSEcCtD
Fluocinolone Acetonide—Rash—Lamotrigine—epilepsy syndrome	0.00013	0.000397	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Lamotrigine—epilepsy syndrome	0.00013	0.000397	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Valproic Acid—epilepsy syndrome	0.00013	0.000396	CcSEcCtD
Fluocinolone Acetonide—Headache—Lamotrigine—epilepsy syndrome	0.000129	0.000395	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000128	0.000391	CcSEcCtD
Fluocinolone Acetonide—Nausea—Carbamazepine—epilepsy syndrome	0.000127	0.000387	CcSEcCtD
Fluocinolone Acetonide—Pain—Pregabalin—epilepsy syndrome	0.000127	0.000387	CcSEcCtD
Fluocinolone Acetonide—Vertigo—Topiramate—epilepsy syndrome	0.000126	0.000384	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000124	0.000378	CcSEcCtD
Fluocinolone Acetonide—Nausea—Lamotrigine—epilepsy syndrome	0.000122	0.000374	CcSEcCtD
Fluocinolone Acetonide—Cough—Topiramate—epilepsy syndrome	0.000122	0.000373	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000121	0.000369	CcSEcCtD
Fluocinolone Acetonide—Fluticasone furoate—ABCB1—epilepsy syndrome	0.00012	0.0142	CrCbGaD
Fluocinolone Acetonide—Arthralgia—Topiramate—epilepsy syndrome	0.000119	0.000364	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000117	0.000358	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Pregabalin—epilepsy syndrome	0.000117	0.000358	CcSEcCtD
Fluocinolone Acetonide—Pain—Gabapentin—epilepsy syndrome	0.000116	0.000355	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Valproic Acid—epilepsy syndrome	0.000116	0.000354	CcSEcCtD
Fluocinolone Acetonide—Oedema—Topiramate—epilepsy syndrome	0.000114	0.000349	CcSEcCtD
Fluocinolone Acetonide—Infection—Topiramate—epilepsy syndrome	0.000114	0.000347	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000112	0.000342	CcSEcCtD
Fluocinolone Acetonide—Nervous system disorder—Topiramate—epilepsy syndrome	0.000112	0.000342	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000109	0.000333	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Valproic Acid—epilepsy syndrome	0.000108	0.000331	CcSEcCtD
Fluocinolone Acetonide—Body temperature increased—Gabapentin—epilepsy syndrome	0.000107	0.000328	CcSEcCtD
Fluocinolone Acetonide—Pruritus—Pregabalin—epilepsy syndrome	0.000105	0.00032	CcSEcCtD
Fluocinolone Acetonide—Vomiting—Valproic Acid—epilepsy syndrome	0.000104	0.000318	CcSEcCtD
Fluocinolone Acetonide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000104	0.000318	CcSEcCtD
Fluocinolone Acetonide—Dexamethasone—ABCC2—epilepsy syndrome	0.000104	0.0124	CrCbGaD
Fluocinolone Acetonide—Rash—Valproic Acid—epilepsy syndrome	0.000103	0.000316	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Valproic Acid—epilepsy syndrome	0.000103	0.000315	CcSEcCtD
Fluocinolone Acetonide—Headache—Valproic Acid—epilepsy syndrome	0.000103	0.000314	CcSEcCtD
Fluocinolone Acetonide—Diarrhoea—Pregabalin—epilepsy syndrome	0.000101	0.00031	CcSEcCtD
Fluocinolone Acetonide—Hypersensitivity—Gabapentin—epilepsy syndrome	0.0001	0.000306	CcSEcCtD
Fluocinolone Acetonide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.87e-05	0.000301	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Pregabalin—epilepsy syndrome	9.8e-05	0.000299	CcSEcCtD
Fluocinolone Acetonide—Pain—Topiramate—epilepsy syndrome	9.77e-05	0.000299	CcSEcCtD
Fluocinolone Acetonide—Nausea—Valproic Acid—epilepsy syndrome	9.73e-05	0.000297	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	9.63e-05	0.0014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	9.62e-05	0.0014	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Gabapentin—epilepsy syndrome	9.61e-05	0.000294	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Endothelins—AKT1—epilepsy syndrome	9.58e-05	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CACNA2D2—epilepsy syndrome	9.57e-05	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLCO1A2—epilepsy syndrome	9.57e-05	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PFKL—epilepsy syndrome	9.57e-05	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—KCNB1—epilepsy syndrome	9.57e-05	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC6A8—epilepsy syndrome	9.57e-05	0.00139	CbGpPWpGaD
Fluocinolone Acetonide—Methylprednisolone—ABCB1—epilepsy syndrome	9.53e-05	0.0113	CrCbGaD
Fluocinolone Acetonide—Triamcinolone—PTGS2—epilepsy syndrome	9.45e-05	0.0112	CrCbGaD
Fluocinolone Acetonide—Vomiting—Pregabalin—epilepsy syndrome	9.42e-05	0.000288	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ARHGEF9—epilepsy syndrome	9.39e-05	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR8—epilepsy syndrome	9.39e-05	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NPY2R—epilepsy syndrome	9.39e-05	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—SSTR1—epilepsy syndrome	9.39e-05	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR9—epilepsy syndrome	9.39e-05	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	9.35e-05	0.00136	CbGpPWpGaD
Fluocinolone Acetonide—Rash—Pregabalin—epilepsy syndrome	9.34e-05	0.000285	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Pregabalin—epilepsy syndrome	9.33e-05	0.000285	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	9.3e-05	0.00135	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Gabapentin—epilepsy syndrome	9.29e-05	0.000284	CcSEcCtD
Fluocinolone Acetonide—Headache—Pregabalin—epilepsy syndrome	9.28e-05	0.000283	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—AGE/RAGE pathway—AKT1—epilepsy syndrome	9.23e-05	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GRM4—epilepsy syndrome	9.21e-05	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GRM3—epilepsy syndrome	9.21e-05	0.00134	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—ABCG2—epilepsy syndrome	9.2e-05	0.0109	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—SSTR2—epilepsy syndrome	9.04e-05	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	9.04e-05	0.00131	CbGpPWpGaD
Fluocinolone Acetonide—Body temperature increased—Topiramate—epilepsy syndrome	9.03e-05	0.000276	CcSEcCtD
Fluocinolone Acetonide—Dizziness—Gabapentin—epilepsy syndrome	8.98e-05	0.000274	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—PDGFR-beta signaling pathway—SRC—epilepsy syndrome	8.91e-05	0.0013	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Pregabalin—epilepsy syndrome	8.8e-05	0.000269	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ADRA2A—epilepsy syndrome	8.77e-05	0.00128	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ATIC—epilepsy syndrome	8.75e-05	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—UPB1—epilepsy syndrome	8.75e-05	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NEU1—epilepsy syndrome	8.75e-05	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAT—epilepsy syndrome	8.74e-05	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GRM8—epilepsy syndrome	8.73e-05	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—QARS—epilepsy syndrome	8.71e-05	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	8.71e-05	0.00127	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Gabapentin—epilepsy syndrome	8.64e-05	0.000264	CcSEcCtD
Fluocinolone Acetonide—Rash—Gabapentin—epilepsy syndrome	8.56e-05	0.000262	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Gabapentin—epilepsy syndrome	8.56e-05	0.000261	CcSEcCtD
Fluocinolone Acetonide—Headache—Gabapentin—epilepsy syndrome	8.51e-05	0.00026	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ACKR4—epilepsy syndrome	8.44e-05	0.00123	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HSD17B4—epilepsy syndrome	8.43e-05	0.00122	CbGpPWpGaD
Fluocinolone Acetonide—Hypersensitivity—Topiramate—epilepsy syndrome	8.42e-05	0.000257	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—OPRD1—epilepsy syndrome	8.33e-05	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GNAO1—epilepsy syndrome	8.33e-05	0.00121	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	8.27e-05	0.0012	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS1—epilepsy syndrome	8.21e-05	0.00119	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PPP1R3C—epilepsy syndrome	8.14e-05	0.00118	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GBE1—epilepsy syndrome	8.14e-05	0.00118	CbGpPWpGaD
Fluocinolone Acetonide—Pruritus—Topiramate—epilepsy syndrome	8.08e-05	0.000247	CcSEcCtD
Fluocinolone Acetonide—Nausea—Gabapentin—epilepsy syndrome	8.07e-05	0.000246	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—ALB—epilepsy syndrome	7.99e-05	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR7—epilepsy syndrome	7.98e-05	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PDYN—epilepsy syndrome	7.98e-05	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GRM1—epilepsy syndrome	7.98e-05	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CHRM1—epilepsy syndrome	7.98e-05	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	7.95e-05	0.00116	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—NR3C1—epilepsy syndrome	7.93e-05	0.00944	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	7.85e-05	0.00114	CbGpPWpGaD
Fluocinolone Acetonide—Diarrhoea—Topiramate—epilepsy syndrome	7.82e-05	0.000239	CcSEcCtD
Fluocinolone Acetonide—Betamethasone—PTGS2—epilepsy syndrome	7.74e-05	0.00921	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT3—epilepsy syndrome	7.69e-05	0.00112	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ASAH1—epilepsy syndrome	7.65e-05	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SSTR4—epilepsy syndrome	7.64e-05	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SSTR5—epilepsy syndrome	7.64e-05	0.00111	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAUR—epilepsy syndrome	7.6e-05	0.0011	CbGpPWpGaD
Fluocinolone Acetonide—Dizziness—Topiramate—epilepsy syndrome	7.56e-05	0.000231	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GAL—epilepsy syndrome	7.51e-05	0.00109	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—STXBP1—epilepsy syndrome	7.44e-05	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GRM5—epilepsy syndrome	7.42e-05	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CHRM3—epilepsy syndrome	7.42e-05	0.00108	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR10—epilepsy syndrome	7.32e-05	0.00106	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	7.29e-05	0.00106	CbGpPWpGaD
Fluocinolone Acetonide—Vomiting—Topiramate—epilepsy syndrome	7.27e-05	0.000222	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALAD—epilepsy syndrome	7.25e-05	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—NT5E—epilepsy syndrome	7.25e-05	0.00105	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—CYP2C19—epilepsy syndrome	7.23e-05	0.00861	CrCbGaD
Fluocinolone Acetonide—Rash—Topiramate—epilepsy syndrome	7.21e-05	0.00022	CcSEcCtD
Fluocinolone Acetonide—Dermatitis—Topiramate—epilepsy syndrome	7.2e-05	0.00022	CcSEcCtD
Fluocinolone Acetonide—Headache—Topiramate—epilepsy syndrome	7.16e-05	0.000219	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CX3CR1—epilepsy syndrome	7.12e-05	0.00103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.08e-05	0.00103	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—CDC42—epilepsy syndrome	7.02e-05	0.00102	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—BDKRB1—epilepsy syndrome	6.98e-05	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CHRM2—epilepsy syndrome	6.98e-05	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CX3CL1—epilepsy syndrome	6.98e-05	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF2B5—epilepsy syndrome	6.96e-05	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALDH7A1—epilepsy syndrome	6.92e-05	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CACNA1A—epilepsy syndrome	6.92e-05	0.00101	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—GABBR1—epilepsy syndrome	6.79e-05	0.000987	CbGpPWpGaD
Fluocinolone Acetonide—Nausea—Topiramate—epilepsy syndrome	6.79e-05	0.000207	CcSEcCtD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ST3GAL3—epilepsy syndrome	6.77e-05	0.000984	CbGpPWpGaD
Fluocinolone Acetonide—Prednisolone—ABCB1—epilepsy syndrome	6.72e-05	0.00799	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ADSL—epilepsy syndrome	6.63e-05	0.000964	CbGpPWpGaD
Fluocinolone Acetonide—Betamethasone—ABCB1—epilepsy syndrome	6.58e-05	0.00783	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HRH3—epilepsy syndrome	6.51e-05	0.000946	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GLUL—epilepsy syndrome	6.51e-05	0.000946	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—OPRM1—epilepsy syndrome	6.41e-05	0.000931	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM2—epilepsy syndrome	6.4e-05	0.00093	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CACNA1D—epilepsy syndrome	6.39e-05	0.000928	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.35e-05	0.000923	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—JUNB—epilepsy syndrome	6.34e-05	0.000922	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—TFAM—epilepsy syndrome	6.3e-05	0.000915	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—FYN—epilepsy syndrome	6.25e-05	0.000908	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.19e-05	0.000899	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	6.08e-05	0.000883	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	6.06e-05	0.000881	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR3—epilepsy syndrome	6.05e-05	0.00088	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—YWHAZ—epilepsy syndrome	6.01e-05	0.000873	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TXNRD1—epilepsy syndrome	5.97e-05	0.000868	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—NPY—epilepsy syndrome	5.9e-05	0.000857	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	5.89e-05	0.000856	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AQP1—epilepsy syndrome	5.8e-05	0.000843	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SSTR3—epilepsy syndrome	5.79e-05	0.000841	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL2—epilepsy syndrome	5.69e-05	0.000827	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—OXT—epilepsy syndrome	5.69e-05	0.000827	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL3—epilepsy syndrome	5.69e-05	0.000827	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CRH—epilepsy syndrome	5.69e-05	0.000827	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ST3GAL3—epilepsy syndrome	5.66e-05	0.000823	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	5.65e-05	0.000821	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.57e-05	0.00081	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ARHGEF9—epilepsy syndrome	5.55e-05	0.000806	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR8—epilepsy syndrome	5.55e-05	0.000806	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR9—epilepsy syndrome	5.55e-05	0.000806	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SSTR1—epilepsy syndrome	5.55e-05	0.000806	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NPY2R—epilepsy syndrome	5.55e-05	0.000806	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—epilepsy syndrome	5.55e-05	0.000806	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	5.5e-05	0.0008	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—epilepsy syndrome	5.49e-05	0.000798	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM3—epilepsy syndrome	5.44e-05	0.000791	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM4—epilepsy syndrome	5.44e-05	0.000791	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SNRPE—epilepsy syndrome	5.44e-05	0.00079	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—CYP2D6—epilepsy syndrome	5.36e-05	0.00638	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SSTR2—epilepsy syndrome	5.34e-05	0.000776	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DUSP4—epilepsy syndrome	5.34e-05	0.000776	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PLAU—epilepsy syndrome	5.33e-05	0.000775	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.3e-05	0.00077	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CHRM3—epilepsy syndrome	5.24e-05	0.000762	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—KCNJ11—epilepsy syndrome	5.24e-05	0.000762	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM8—epilepsy syndrome	5.16e-05	0.00075	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PGF—epilepsy syndrome	5.16e-05	0.00075	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	5.15e-05	0.000748	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—SST—epilepsy syndrome	5.15e-05	0.000748	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR2—epilepsy syndrome	5.15e-05	0.000748	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Adipogenesis—TNF—epilepsy syndrome	5.1e-05	0.000742	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—ADRA2A—epilepsy syndrome	5.04e-05	0.000732	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Generic Transcription Pathway—VDR—epilepsy syndrome	5.03e-05	0.000731	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—PRKCB—epilepsy syndrome	4.96e-05	0.00072	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GNAO1—epilepsy syndrome	4.92e-05	0.000715	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—OPRD1—epilepsy syndrome	4.92e-05	0.000715	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—NOS2—epilepsy syndrome	4.9e-05	0.000712	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.88e-05	0.00071	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—BDKRB2—epilepsy syndrome	4.84e-05	0.000703	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CXCL12—epilepsy syndrome	4.84e-05	0.000703	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.79e-05	0.000696	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CNR1—epilepsy syndrome	4.75e-05	0.00069	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PLCB1—epilepsy syndrome	4.73e-05	0.000688	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CHRM1—epilepsy syndrome	4.72e-05	0.000686	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR7—epilepsy syndrome	4.72e-05	0.000686	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PDYN—epilepsy syndrome	4.72e-05	0.000686	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM1—epilepsy syndrome	4.72e-05	0.000686	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR7—epilepsy syndrome	4.63e-05	0.000673	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—PTGS2—epilepsy syndrome	4.5e-05	0.00536	CrCbGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HBEGF—epilepsy syndrome	4.5e-05	0.000654	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GAL—epilepsy syndrome	4.43e-05	0.000645	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GFAP—epilepsy syndrome	4.43e-05	0.000645	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT3—epilepsy syndrome	4.41e-05	0.000642	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	4.41e-05	0.000641	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CHRM3—epilepsy syndrome	4.39e-05	0.000637	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP2—epilepsy syndrome	4.39e-05	0.000637	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GRM5—epilepsy syndrome	4.39e-05	0.000637	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCG2—epilepsy syndrome	4.28e-05	0.000621	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CX3CR1—epilepsy syndrome	4.2e-05	0.000611	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2C19—epilepsy syndrome	4.17e-05	0.000606	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP11A1—epilepsy syndrome	4.14e-05	0.000602	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CHRM2—epilepsy syndrome	4.12e-05	0.000599	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CX3CL1—epilepsy syndrome	4.12e-05	0.000599	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BDKRB1—epilepsy syndrome	4.12e-05	0.000599	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—ALB—epilepsy syndrome	4.12e-05	0.000598	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.11e-05	0.000597	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CDC42—epilepsy syndrome	4.03e-05	0.000585	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—GABBR1—epilepsy syndrome	4.01e-05	0.000583	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	3.95e-05	0.000574	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AVP—epilepsy syndrome	3.9e-05	0.000567	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HRH3—epilepsy syndrome	3.85e-05	0.000559	CbGpPWpGaD
Fluocinolone Acetonide—Dexamethasone—ABCB1—epilepsy syndrome	3.83e-05	0.00456	CrCbGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—EIF2S1—epilepsy syndrome	3.79e-05	0.000551	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—OPRM1—epilepsy syndrome	3.79e-05	0.00055	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.75e-05	0.000545	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CYP2D6—epilepsy syndrome	3.74e-05	0.000543	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—HSPB1—epilepsy syndrome	3.66e-05	0.000532	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR3—epilepsy syndrome	3.57e-05	0.00052	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ADRA2A—epilepsy syndrome	3.56e-05	0.000517	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—BCHE—epilepsy syndrome	3.54e-05	0.000515	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	3.51e-05	0.00051	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ATP2A2—epilepsy syndrome	3.48e-05	0.000506	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NPY—epilepsy syndrome	3.48e-05	0.000506	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—SLC2A1—epilepsy syndrome	3.38e-05	0.000491	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HSPB1—epilepsy syndrome	3.36e-05	0.000488	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL2—epilepsy syndrome	3.36e-05	0.000488	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—OXT—epilepsy syndrome	3.36e-05	0.000488	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL3—epilepsy syndrome	3.36e-05	0.000488	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CRH—epilepsy syndrome	3.36e-05	0.000488	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PLCB1—epilepsy syndrome	3.34e-05	0.000486	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—TH—epilepsy syndrome	3.33e-05	0.000484	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCR5—epilepsy syndrome	3.32e-05	0.000482	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.28e-05	0.000477	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—HTR2A—epilepsy syndrome	3.24e-05	0.000472	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PTK2B—epilepsy syndrome	3.12e-05	0.000454	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSC1—epilepsy syndrome	3.12e-05	0.000454	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AGT—epilepsy syndrome	3.08e-05	0.000447	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—JUNB—epilepsy syndrome	3.05e-05	0.000444	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR2—epilepsy syndrome	3.04e-05	0.000442	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SST—epilepsy syndrome	3.04e-05	0.000442	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NTRK2—epilepsy syndrome	3.04e-05	0.000442	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—DUSP6—epilepsy syndrome	3.01e-05	0.000438	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADRA2A—epilepsy syndrome	2.97e-05	0.000432	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLAT—epilepsy syndrome	2.96e-05	0.000431	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—SRC—epilepsy syndrome	2.91e-05	0.000423	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CXCL12—epilepsy syndrome	2.86e-05	0.000415	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.86e-05	0.000415	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.84e-05	0.000413	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—VEGFA—epilepsy syndrome	2.84e-05	0.000412	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.83e-05	0.000412	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUNB—epilepsy syndrome	2.81e-05	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CNR1—epilepsy syndrome	2.81e-05	0.000408	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PLCB1—epilepsy syndrome	2.79e-05	0.000406	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—HMOX1—epilepsy syndrome	2.78e-05	0.000404	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—CAT—epilepsy syndrome	2.74e-05	0.000399	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR7—epilepsy syndrome	2.74e-05	0.000398	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ABCB1—epilepsy syndrome	2.67e-05	0.000388	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HBEGF—epilepsy syndrome	2.66e-05	0.000386	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT3—epilepsy syndrome	2.61e-05	0.000379	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—POMC—epilepsy syndrome	2.59e-05	0.000377	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—ADAM10—epilepsy syndrome	2.55e-05	0.00037	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—CCL2—epilepsy syndrome	2.54e-05	0.000369	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—GPX1—epilepsy syndrome	2.48e-05	0.000361	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—SIRT1—epilepsy syndrome	2.46e-05	0.000357	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—VDR—epilepsy syndrome	2.42e-05	0.000352	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—S100B—epilepsy syndrome	2.41e-05	0.00035	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SOCS3—epilepsy syndrome	2.39e-05	0.000347	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CDC42—epilepsy syndrome	2.38e-05	0.000346	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AVP—epilepsy syndrome	2.3e-05	0.000335	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—H2AFX—epilepsy syndrome	2.3e-05	0.000334	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—YWHAZ—epilepsy syndrome	2.22e-05	0.000322	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HES1—epilepsy syndrome	2.18e-05	0.000317	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AGT—epilepsy syndrome	2.18e-05	0.000316	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—APOE—epilepsy syndrome	2.13e-05	0.00031	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FYN—epilepsy syndrome	2.12e-05	0.000308	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—H2AFX—epilepsy syndrome	2.11e-05	0.000307	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MEF2C—epilepsy syndrome	2.11e-05	0.000306	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.04e-05	0.000296	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—NGF—epilepsy syndrome	2.01e-05	0.000293	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCR5—epilepsy syndrome	1.96e-05	0.000285	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—HTR2A—epilepsy syndrome	1.92e-05	0.000279	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—POMC—epilepsy syndrome	1.83e-05	0.000266	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—TSC2—epilepsy syndrome	1.82e-05	0.000265	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AGT—epilepsy syndrome	1.82e-05	0.000264	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Hemostasis—AKT1—epilepsy syndrome	1.81e-05	0.000263	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—APOE—epilepsy syndrome	1.78e-05	0.000259	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—KDR—epilepsy syndrome	1.75e-05	0.000254	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—PRKCB—epilepsy syndrome	1.68e-05	0.000244	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—IL6ST—epilepsy syndrome	1.67e-05	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—ALB—epilepsy syndrome	1.67e-05	0.000243	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—POMC—epilepsy syndrome	1.53e-05	0.000222	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CCL2—epilepsy syndrome	1.5e-05	0.000218	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—PTGS2—epilepsy syndrome	1.46e-05	0.000212	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—FGF2—epilepsy syndrome	1.35e-05	0.000197	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—RELA—epilepsy syndrome	1.26e-05	0.000183	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MTOR—epilepsy syndrome	1.23e-05	0.000179	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—CASP3—epilepsy syndrome	1.13e-05	0.000165	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—JUN—epilepsy syndrome	1.1e-05	0.00016	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—MMP9—epilepsy syndrome	1.07e-05	0.000156	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling by GPCR—AKT1—epilepsy syndrome	1.04e-05	0.000151	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—SRC—epilepsy syndrome	9.88e-06	0.000144	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—VEGFA—epilepsy syndrome	9.62e-06	0.00014	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Metabolism—AKT1—epilepsy syndrome	7.34e-06	0.000107	CbGpPWpGaD
Fluocinolone Acetonide—NR3C1—Gene Expression—AKT1—epilepsy syndrome	6.68e-06	9.71e-05	CbGpPWpGaD
Fluocinolone Acetonide—PLA2G4A—Signaling Pathways—AKT1—epilepsy syndrome	6.14e-06	8.92e-05	CbGpPWpGaD
